Cart
sales@molnova.com
Pimavanserin tartrate
CAS No. 706782-28-7
Pimavanserin tartrate ( ACP-103 tartrate )
Catalog No. M19024 CAS No. 706782-28-7
Pimavanserin is an effective and specific serotonin 5-HT2A inverse agonist (pIC50: 8.73), used in the therapy of psychosis associated with Parkinson’s disease.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 39 | In Stock |
|
| 50MG | 61 | In Stock |
|
| 100MG | 102 | In Stock |
|
| 200MG | 131 | In Stock |
|
| 500MG | 218 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePimavanserin tartrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPimavanserin is an effective and specific serotonin 5-HT2A inverse agonist (pIC50: 8.73), used in the therapy of psychosis associated with Parkinson’s disease.
-
DescriptionPimavanserin is an effective and specific serotonin 5-HT2A inverse agonist (pIC50: 8.73), used in the therapy of psychosis associated with Parkinson’s disease.
-
SynonymsACP-103 tartrate
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptor5-HT2A
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number706782-28-7
-
Formula Weight1005.2
-
Molecular FormulaC50H68F2N6O4·C4H6O6
-
Purity98%
-
SolubilityDMSO : ≥ 75 mg/mL; 74.61 mM
-
SMILESCC(C)COc1ccc(cc1)CNC(=O)N(Cc1ccc(cc1)F)C1CCN(CC1)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.CC(C)COc1ccc(cc1)CNC(=O)N(Cc1ccc(cc1)F)C1CCN(CC1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vanover KE, et al. J Pharmacol Exp Ther. 2006 May;317(2):910-8.
molnova catalog
related products
-
Oxprenolol hydrochlo...
Oxprenolol hydrochloride is a non-selectiveβ-adrenergic blocking agent(Ki = 7.10 nM).
-
Methoxyphenamine Hyd...
Methoxyphenamine is a β-adrenergic receptor agonist of the amphetamine class used as a bronchodilator.
-
Amezinium (methylsul...
Amezinium metilsulfate has multiple mechanisms including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.
